249 related articles for article (PubMed ID: 28726062)
1. Valproic Acid in Women and Girls of Childbearing Age.
Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
[TBL] [Abstract][Full Text] [Related]
2. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present.
García-Portilla MP; Bobes J
Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547
[No Abstract] [Full Text] [Related]
3. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
Reynolds MF; Sisk EC; Rasgon NL
Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
[TBL] [Abstract][Full Text] [Related]
4. On the association between valproate and polycystic ovary syndrome.
Genton P; Bauer J; Duncan S; Taylor AE; Balen AH; Eberle A; Pedersen B; Salas-Puig X; Sauer MV
Epilepsia; 2001 Mar; 42(3):295-304. PubMed ID: 11442143
[TBL] [Abstract][Full Text] [Related]
5. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
6. Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.
Bosak M; Słowik A; Turaj W
Epilepsy Behav; 2019 Sep; 98(Pt A):1-5. PubMed ID: 31299525
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
[TBL] [Abstract][Full Text] [Related]
8. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
9. Guideline adherence for mentally ill reproductive-aged women on treatment with valproic acid: a retrospective chart review.
Gotlib D; Perelstein E; Kurlander J; Zivin K; Riba M; Muzik M
J Clin Psychiatry; 2016 Apr; 77(4):527-34. PubMed ID: 27137421
[TBL] [Abstract][Full Text] [Related]
10. [Caution and warning: About valproate and pregnancy].
Masson M; Huberfeld G; Richa S; Henry C; Gaillard R
Encephale; 2016 Oct; 42(5):391-394. PubMed ID: 27842894
[No Abstract] [Full Text] [Related]
11. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
12. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
Goldspink R; Pumipi T; Dey S; Menkes DB
Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
[TBL] [Abstract][Full Text] [Related]
13. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
Jentink J; Bakker MK; Nijenhuis CM; Wilffert B; de Jong-van den Berg LT
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):803-7. PubMed ID: 20680999
[TBL] [Abstract][Full Text] [Related]
14. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
Vasudev K; Mead A
Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
[No Abstract] [Full Text] [Related]
15. Reproductive function and risk for PCOS in women treated for bipolar disorder.
Rasgon NL; Altshuler LL; Fairbanks L; Elman S; Bitran J; Labarca R; Saad M; Kupka R; Nolen WA; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich G; Grunze H; Walden J; Post R; Mintz J
Bipolar Disord; 2005 Jun; 7(3):246-59. PubMed ID: 15898962
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome in women using valproate: a review.
Bilo L; Meo R
Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid: long-term effects on children exposed in utero.
Prescrire Int; 2009 Dec; 18(104):253-7. PubMed ID: 20025093
[TBL] [Abstract][Full Text] [Related]
18. Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta-analysis.
Tanoshima M; Kobayashi T; Tanoshima R; Beyene J; Koren G; Ito S
Clin Pharmacol Ther; 2015 Oct; 98(4):417-41. PubMed ID: 26044279
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S
Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
[TBL] [Abstract][Full Text] [Related]
20. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
